Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.024 AUD | +14.29% | -11.11% | -31.43% |
01:36am | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
05-16 | Chimeric Therapeutics Reopens Enrollment in Phase 1B Cell Therapy Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.43% | 12.02M | |
+9.97% | 115B | |
+11.89% | 106B | |
-2.59% | 21.96B | |
-12.45% | 21.87B | |
-5.29% | 19.21B | |
-3.70% | 18.08B | |
-38.57% | 17.71B | |
+7.13% | 14.32B | |
+35.75% | 12.42B |
- Stock Market
- Equities
- CHM Stock
- News Chimeric Therapeutics Limited
- Chimeric Therapeutics Extends Share Purchase Plan Closing Date; Shares Up 3%